Drug
OM 40
OM 40: highest development phase Phase 3, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| OM 40 NCT00441350 | Phase 3 | Hypertension |
Latest
No recent events.
Follow OM 40 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.